FDA Investigator

Sarah E Mcmullen

Latest inspection on record: Yinchuan, China, August 2014 · records back to 2008

Animal Drugs & FeedsHuman Drugs

FDA inspection record · Last updated July 12, 2026

Overview

  • 30 inspections across 30 sites are on record.
  • 111 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2014-08-01.

At a glance

Inspections

30

Sites

30

Observations

111

Career since

Feb 2008

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Ningxia Tairui Pharmaceutical Co., Ltd.1 Aug 2014Animal Drugs & FeedsOn file
Nanhai Beisha Pharmaceutical Co., Ltd.25 Jul 2014Animal Drugs & FeedsOn file
Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd.16 Jul 2014Animal Drugs & FeedsOn file
Opella Healthcare International SAS19 Sep 2013Human DrugsView 483 →
Nucro-Technics, Inc.11 Sep 2013Human DrugsView 483 →

Sites inspected

Nanhai Beisha Pharmaceutical Co., Ltd.Nanhai, Foshan, China1 insp.
Opella Healthcare International SASCompiegne, France1 insp.
Nucro-Technics, Inc.Scarborough, Canada1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Sarah E Mcmullen's 111 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site